Welcome to our dedicated page for Medirom Healthcare Technologies SEC filings (Ticker: MRM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
MEDIROM Healthcare Technologies Inc. filings document a foreign private issuer that reports to the SEC on Form 6-K and annual reports under Form 20-F. The company’s disclosures cover its Japan-based wellness salon operations, digital preventive healthcare products, ADR/ADS voting materials, and current reports furnished for press releases and material corporate events.
MRM filings include ordinary general meeting notices and proxy cards for common share and American Depositary Share holders, convertible-type corporate bond issuances under Japanese law, loan and maturity-extension agreements, registration statement incorporation references, KPI reporting changes, and partnership updates for World ID, Orb authentication, MOTHER Bracelet and REMONY. These records also describe capital structure, governance procedures, financing terms, risk language and foreign-issuer reporting mechanics.
Healthcare Technologies Inc. has received a Nasdaq notice stating it is not in compliance with Nasdaq Listing Rule 5250(c)(1) because it failed to timely file its Form 20-F for the year ended December 31, 2025. The notice does not immediately affect trading of its American Depositary Shares on the Nasdaq Capital Market.
The company has 60 days from the May 26, 2026 notice, until July 27, 2026, to submit a plan to regain compliance, and Nasdaq may grant up to 180 days, until November 11, 2026, to cure the deficiency if the plan is accepted. Healthcare Technologies plans to file its Form 20-F or provide a compliance plan by July 27, 2026, but there is no assurance Nasdaq will accept the plan or extend the deadline.
Healthcare Technologies Inc. reported key operating metrics for the first quarter of 2026, highlighting trends across its salon, World ID, and HealthTech businesses. The salon segment generated Average Revenue Per Customer of 7,822 JPY, a 7.7% year-on-year increase and well above a referenced Japanese industry average.
The number of salons was 287 and total customers were 192k, with customer count down 13.9% year on year. Repeat ratio was 78.0% and operating ratio 44.0%. Independent contractors reached 45.1% of therapists and 53% of total workforce. World ID verifications totaled about 31,000, with 10,552 new verifications in 2026Q1. The Lav® HealthTech business served 106 insurers and 13,226 cumulative users as of 2026Q1.
Healthcare Technologies Inc. has called its 26th Ordinary General Meeting of Shareholders for May 29, 2026 to approve Japanese GAAP non‑consolidated financial statements for fiscal 2025 and elect five directors, including two outside directors. The board unanimously recommends voting “FOR” all proposals and stresses the importance of proxy voting for holders unable to attend in Tokyo.
Under Japanese GAAP, fiscal 2025 revenue was JPY 604,533 thousand and net income was JPY 56,058 thousand, with a capital adequacy ratio of 32.11%. The company continued reorganizing its relaxation salon operations, expanded its healthtech and rehabilitation businesses, and raised JPY 400 million via 3rd series unsecured convertible‑type bonds. It also issued a 4th series of convertible‑type bonds with a balance of JPY 275 million and maintained total assets of JPY 4,153,929 thousand and net assets per common share of JPY 168.32 at year‑end.
Healthcare Technologies Inc. entered a new Memorandum of Understanding with Kufu Company Holdings Inc. on March 31, 2026 to adjust an existing financing arrangement. The parties agreed to extend the maturity date of their previously disclosed Deemed Loan Agreement from March 31, 2026 to April 30, 2026, giving the Company an extra month before repaying principal under that loan. All interest that had accrued through March 31, 2026 under the Loan Agreement became due and payable when this new memorandum was executed, while all other loan terms remain unchanged. The company is also incorporating this report, including the exhibit containing the memorandum, by reference into its existing registration statements on Form S-8 and Form F-3.
Kufu Company Holdings, Inc. filed an amended ownership report on Medirom Healthcare Technologies Inc., showing beneficial ownership of 833,333 common shares, or 9.44% of the company on an as-converted basis. These shares are issuable upon conversion of unsecured convertible-type corporate bonds.
On December 31, 2025, Kufu purchased Medirom’s Fourth Unsecured Convertible-Type Corporate Bonds with share options for an aggregate JPY 275,000,000, funded with cash on hand. The bonds bear 5.0% annual interest until the June 30, 2026 maturity date, with a possible extension to December 25, 2026, and are convertible at JPY 330 per common share.
The filing explains that part of the new bonds refinanced JPY 275,000,000 of principal from earlier convertible bonds issued in 2022 that matured on December 31, 2025. Kufu states it holds the investment for general investment purposes and may reassess its position based on Medirom’s performance and market conditions.
Medirom Healthcare Technologies Inc. director Ogawa Tomoya filed an initial ownership report showing he directly holds 28,500 Common Shares of the company. This filing is a baseline disclosure of his equity stake and does not reflect any new share purchases or sales.
Medirom Healthcare Technologies Inc. director Nojima Akira has reported initial beneficial ownership of 1,200 Common Shares. These shares are held directly, and the filing does not reflect any recent buy or sell activity, only the director’s current equity position in the company.
Medirom Healthcare Technologies Inc. filed an initial ownership report for Chief Financial Officer and director Fujiwara Fumitoshi. The filing shows direct beneficial ownership of 40,000 Common Shares following the reported position. This Form 3 does not reflect any new purchase or sale transactions, only the existing holdings.
Medirom Healthcare Technologies Inc. director and Chief Executive Officer Eguchi Kouji filed an initial ownership report showing his existing stake in the company. He directly holds 1,877,460 common shares, plus additional indirect holdings, and holds options to purchase 150,000 common shares and 36,500 common shares at stated exercise prices and terms.
Healthcare Technologies Inc. reported that its Master Service Agreement with Tools for Humanity and World Foundation became effective on February 2, 2026. The partnership is tied to deployment of Orbs biometric devices in Japan.
The company currently has Orbs at more than 150 locations, with cumulative authentications exceeding 20,000. Based on current performance, if it expands to about 3,000 locations nationwide in Japan, Healthcare Technologies estimates it could generate approximately USD 39 million (about JPY 6.10 billion) in income before income taxes over the next two years under the agreement, though this projection is forward-looking and subject to risks.